Matches in SemOpenAlex for { <https://semopenalex.org/work/W2017696543> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W2017696543 endingPage "677" @default.
- W2017696543 startingPage "671" @default.
- W2017696543 abstract "The aim of this study was to compare the efficacy and safety of intramuscular ziprasidone versus intramuscular (i.m.) olanzapine in treating aggression in youth.A retrospective chart review of 100 hospitalized patients less than 18 years of age treated with either i.m. ziprasidone or i.m. olanzapine for agitation or aggression was conducted. Comparisons were performed using statistical analysis of data collected from medical records.Baseline demographics were similar in the i.m. olanzapine and ziprasidone treatment groups regarding age and ethnicity; however, gender differences did reach statistical significance (p < 0.001). Dosing between children and adolescents significantly differed in the olanzapine group, whereas dosing was comparable in the ziprasidone group. No significant differences between the olanzapine and ziprasidone treatment groups were noted regarding length of stay, efficacy of the study medications, number of restraints, and duration of restraints. Ziprasidone subjects received significantly more doses of emergency medication during their hospital stay and significantly more doses of ziprasidone were administered with concomitant lorazepam or antihistamines.The results suggest i.m. ziprasidone and intramuscular olanzapine may be equally effective in treating aggression in youth. These agents may also be similar with regard to safety because no clinically significant adverse events were reported for either treatment group. The possibility of poor documentation of adverse events and side effects prevents formulating definitive conclusions regarding safety from this study." @default.
- W2017696543 created "2016-06-24" @default.
- W2017696543 creator A5062846060 @default.
- W2017696543 creator A5069753077 @default.
- W2017696543 date "2006-12-01" @default.
- W2017696543 modified "2023-09-26" @default.
- W2017696543 title "A Naturalistic Evaluation of Intramuscular Ziprasidone Versus Intramuscular Olanzapine for the Management of Acute Agitation and Aggression in Children and Adolescents" @default.
- W2017696543 cites W2003393849 @default.
- W2017696543 cites W2020085742 @default.
- W2017696543 cites W2037172357 @default.
- W2017696543 cites W2077206280 @default.
- W2017696543 cites W2086011500 @default.
- W2017696543 cites W2098793168 @default.
- W2017696543 cites W2158988332 @default.
- W2017696543 cites W2171532531 @default.
- W2017696543 cites W4240749213 @default.
- W2017696543 doi "https://doi.org/10.1089/cap.2006.16.671" @default.
- W2017696543 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17201611" @default.
- W2017696543 hasPublicationYear "2006" @default.
- W2017696543 type Work @default.
- W2017696543 sameAs 2017696543 @default.
- W2017696543 citedByCount "42" @default.
- W2017696543 countsByYear W20176965432012 @default.
- W2017696543 countsByYear W20176965432013 @default.
- W2017696543 countsByYear W20176965432014 @default.
- W2017696543 countsByYear W20176965432016 @default.
- W2017696543 countsByYear W20176965432017 @default.
- W2017696543 countsByYear W20176965432018 @default.
- W2017696543 countsByYear W20176965432019 @default.
- W2017696543 countsByYear W20176965432020 @default.
- W2017696543 countsByYear W20176965432021 @default.
- W2017696543 countsByYear W20176965432022 @default.
- W2017696543 countsByYear W20176965432023 @default.
- W2017696543 crossrefType "journal-article" @default.
- W2017696543 hasAuthorship W2017696543A5062846060 @default.
- W2017696543 hasAuthorship W2017696543A5069753077 @default.
- W2017696543 hasConcept C118552586 @default.
- W2017696543 hasConcept C126322002 @default.
- W2017696543 hasConcept C15744967 @default.
- W2017696543 hasConcept C197934379 @default.
- W2017696543 hasConcept C2776412080 @default.
- W2017696543 hasConcept C2776619155 @default.
- W2017696543 hasConcept C2777270317 @default.
- W2017696543 hasConcept C2777288759 @default.
- W2017696543 hasConcept C42219234 @default.
- W2017696543 hasConcept C71924100 @default.
- W2017696543 hasConceptScore W2017696543C118552586 @default.
- W2017696543 hasConceptScore W2017696543C126322002 @default.
- W2017696543 hasConceptScore W2017696543C15744967 @default.
- W2017696543 hasConceptScore W2017696543C197934379 @default.
- W2017696543 hasConceptScore W2017696543C2776412080 @default.
- W2017696543 hasConceptScore W2017696543C2776619155 @default.
- W2017696543 hasConceptScore W2017696543C2777270317 @default.
- W2017696543 hasConceptScore W2017696543C2777288759 @default.
- W2017696543 hasConceptScore W2017696543C42219234 @default.
- W2017696543 hasConceptScore W2017696543C71924100 @default.
- W2017696543 hasIssue "6" @default.
- W2017696543 hasLocation W20176965431 @default.
- W2017696543 hasLocation W20176965432 @default.
- W2017696543 hasOpenAccess W2017696543 @default.
- W2017696543 hasPrimaryLocation W20176965431 @default.
- W2017696543 hasRelatedWork W1948712038 @default.
- W2017696543 hasRelatedWork W1974450701 @default.
- W2017696543 hasRelatedWork W1988672159 @default.
- W2017696543 hasRelatedWork W2024355407 @default.
- W2017696543 hasRelatedWork W2059444637 @default.
- W2017696543 hasRelatedWork W2093291608 @default.
- W2017696543 hasRelatedWork W2098103756 @default.
- W2017696543 hasRelatedWork W3003172019 @default.
- W2017696543 hasRelatedWork W317413560 @default.
- W2017696543 hasRelatedWork W2335953446 @default.
- W2017696543 hasVolume "16" @default.
- W2017696543 isParatext "false" @default.
- W2017696543 isRetracted "false" @default.
- W2017696543 magId "2017696543" @default.
- W2017696543 workType "article" @default.